These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 22293628)

  • 1. Levels of fibrinogen and thromboelastometry fibrin polymerisation following treatment with desmopressin (DDAVP).
    Sørensen B; Moore G; Hochleitner G; Fenger-Eriksen C
    Thromb Res; 2012 Apr; 129(4):e164-5. PubMed ID: 22293628
    [No Abstract]   [Full Text] [Related]  

  • 2. Intranasal desmopressin (Octim): a safe and efficacious treatment option for children with bleeding disorders.
    Khair K; Baker K; Mathias M; Burgess C; Liesner R
    Haemophilia; 2007 Sep; 13(5):548-51. PubMed ID: 17880442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Permissive hypotension and desmopressin enhance clot formation.
    Rezende-Neto JB; Rizoli SB; Andrade MV; Ribeiro DD; Lisboa TA; Camargos ER; Martins P; Cunha-Melo JR
    J Trauma; 2010 Jan; 68(1):42-50; discussion 50-1. PubMed ID: 20065756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Desmopressin (Minirin) in multiple trauma--a case report].
    Hilbert P; Struck MF; Stuttmann R
    Z Orthop Unfall; 2010 May; 148(3):338-42. PubMed ID: 20135596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential of whole blood coagulation reconstitution by desmopressin and fibrinogen under conditions of hypothermia and acidosis--an in vitro study using rotation thrombelastometry.
    Hanke AA; Dellweg C; Schöchl H; Weber CF; Jüttner B; Johanning K; Görlinger K; Rahe-Meyer N; Kienbaum P
    Scand J Clin Lab Invest; 2011 Jul; 71(4):292-8. PubMed ID: 21663556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological and clinical response to desmopressin (DDAVP) in a retrospective cohort study of children with low von Willebrand factor levels and bleeding history.
    Sánchez-Luceros A; Meschengieser SS; Woods AI; Chuit R; Turdó K; Blanco A; Lazzari MA
    Thromb Haemost; 2010 Nov; 104(5):984-9. PubMed ID: 20886181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of desmopressin in preventing hemorrhagic complications in a patient with Marfan syndrome undergoing cardiac surgery.
    Franchini M; Lippi G; Veneri D
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):325-6. PubMed ID: 16651878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New approach of the treatment of von Willebrand's disease during pregnancy.
    Gojnic M; Fazlagic A; Likic I; Stefanovic A; Vidakovic S; Pervulov M; Petkovic S; Mostic T; Miljic P; Bogdanovic A
    Arch Gynecol Obstet; 2005 Nov; 273(1):35-8. PubMed ID: 16172853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of vaginal bleeding from a pelvic vascular malformation with desmopressin.
    Huang JT; Koerper MA; Frieden IJ; Chamlin SL
    J Pediatr Hematol Oncol; 2006 Dec; 28(12):845-6. PubMed ID: 17164658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologic response to subcutaneous and intranasal therapy with desmopressin in a large Amish kindred with Type 2M von Willebrand disease.
    Sharthkumar A; Greist A; Di Paola J; Winay J; Roberson C; Heiman M; Herbert S; Parameswaran R; Shapiro A
    Haemophilia; 2008 May; 14(3):539-48. PubMed ID: 18312368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of whole blood fibrin-based clot tests in thrombelastography and thromboelastometry.
    Solomon C; Sørensen B; Hochleitner G; Kashuk J; Ranucci M; Schöchl H
    Anesth Analg; 2012 Apr; 114(4):721-30. PubMed ID: 22314689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desmopressin is a transfusion sparing option to reverse platelet dysfunction in patients with severe traumatic brain injury.
    Furay EJ; Daley MJ; Satarasinghe P; Lara S; Aydelotte JD; Teixeira PG; Coopwood TB; Ali S; Brown CVR
    J Trauma Acute Care Surg; 2020 Jan; 88(1):80-86. PubMed ID: 31688782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A trial of desmopressin (1-desamino-8-D-arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery.
    Hackmann T; Gascoyne RD; Naiman SC; Growe GH; Burchill LD; Jamieson WR; Sheps SB; Schechter MT; Townsend GE
    N Engl J Med; 1989 Nov; 321(21):1437-43. PubMed ID: 2682243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemostasis prophylaxis using single dose desmopressin acetate and extended use epsilon aminocaproic acid for adenotonsillectomy in patients with type 1 von Willebrand disease.
    Santoro C; Hsu F; Dimichele DM
    Haemophilia; 2012 Mar; 18(2):200-4. PubMed ID: 21771208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Desmopressin as a hemostatic. Selective treatment is most effective].
    Flordal A; Schött U
    Lakartidningen; 1994 Jan; 91(4):236-8. PubMed ID: 8309329
    [No Abstract]   [Full Text] [Related]  

  • 16. Desmopressin effects on bleeding during functional endoscopic sinus surgery on patients with chronic rhinosinusitis.
    Hajimohamadi F; Hosseini J; Heidari F; Alvandi S; Bastaninezhad S; Ghabasiah A; Tajdini A
    Am J Otolaryngol; 2021; 42(5):103024. PubMed ID: 33838357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [DDAVP (desmopressin or Minirin)].
    Sultan Y
    Rev Prat; 1988 Jun; 38(18):1197. PubMed ID: 3175486
    [No Abstract]   [Full Text] [Related]  

  • 18. Circumcision in a combined factor V and factor VIII deficiency using desmopressin (DDAVP).
    Devecioğlu O; Eryilmaz E; Celik D; Unüvar A; Karakaş Z; Anak S; Ağaoğlu L
    Turk J Pediatr; 2002; 44(2):146-7. PubMed ID: 12026204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of desmopressin effect on primary haemostasis in pediatric patients with aspirin-like defect as hereditary thrombocytopathy.
    Tauer JT; Gneuss A; Lohse JE; Jürgens T; Knöfler R
    Klin Padiatr; 2011 May; 223(3):169-72. PubMed ID: 21509710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of high concentration intranasal and intravenous desmopressin in pediatric patients with mild hemophilia A or mild-to-moderate type 1 von Willebrand disease.
    Gill JC; Ottum M; Schwartz B
    J Pediatr; 2002 May; 140(5):595-9. PubMed ID: 12032528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.